Comprehensive Analysis of Maine’s Research and Development Tax Incentives: Integrating Sales Tax Exemptions and Income Tax Credits

The Maine R&D Sales Tax Exemption provides a 100% waiver of sales and use tax for machinery and equipment used directly and exclusively in research and development. This benefit functions as a front-end capital incentive that complements the Maine Research Expense Tax Credit, which offers a back-end income tax reduction for incremental research-related spending.1

The structural integration of these two tax expenditures reflects a sophisticated legislative strategy designed to attract high-technology investment and sustain industrial innovation within the state. By exempting the acquisition costs of capital assets used for experimental research, the state lowers the initial financial barrier to entry for innovators. Simultaneously, the Research Expense Tax Credit (RETC) incentivizes the ongoing operational commitment to innovation by rewarding businesses that increase their year-over-year investment in human capital and consumable supplies.3 This dual-layered approach is codified under Title 36 of the Maine Revised Statutes, with the sales tax exemption primarily governed by § 1760(32) and the income tax credit by § 5219-K.5 Understanding the interplay between these statutes requires a nuanced examination of the “direct and exclusive” standard for equipment, the federal conformity of qualified research expenses, and the administrative guidance issued by Maine Revenue Services (MRS).5

The Statutory Foundation of the Sales Tax Exemption for Research and Development

The legal mechanism for the sales tax exemption on R&D machinery and equipment is found in 36 M.R.S. § 1760(32), a provision often identified in legislative reports as the “New Machinery for Experimental Research” (NMER) exemption.2 Enacted with the intent to foster a competitive climate for industrial and scientific advancement, § 1760(32) provides a blanket exemption from the standard 5.5% sales and use tax on specific categories of tangible personal property.1 The statute is bifurcated into two distinct operational components: one addressing general experimental and laboratory research, and the other addressing the burgeoning biotechnology sector.2

General Experimental and Laboratory Research Standards

For general R&D, the exemption applies to machinery and equipment used by the purchaser directly and exclusively for research and development in the “experimental and laboratory sense”.2 This phrasing is not accidental; it draws upon established definitions from federal regulations to differentiate between high-level innovation and routine business operations. Maine law explicitly defines “research and development” by what it is not. The statute excludes activities such as ordinary testing or inspecting of materials or products for quality control, efficiency surveys, management studies, consumer surveys, advertising, promotions, or research in connection with literary, historical, or similar projects.2

The “experimental and laboratory sense” requirement means that the machinery must be utilized to discover information that would eliminate technical uncertainty concerning the development or improvement of a product or process.10 This alignment with federal Section 174 standards ensures that taxpayers can rely on consistent documentation across state and federal filings. However, the Maine standard for sales tax is more rigorous than many federal counterparts due to the “exclusively” requirement. In this context, “exclusively” means that the equipment cannot be used for any non-exempt activity, even on an incidental basis.2 If a machine is used for 90% research and 10% production or quality control, the entire exemption is forfeited, as it fails the 100% exclusivity threshold.2

Biotechnology Special Provisions and “Directly and Primarily” Usage

Recognizing the unique capital requirements and experimental nature of the life sciences industry, § 1760(32) provides a secondary, more lenient standard for biotechnology applications.1 For biotechnology firms, the exemption covers machinery, equipment, instruments, and supplies used “directly and primarily” in a biotechnology application.1 The shift from “exclusively” to “primarily” is a significant departure in the law. Under Maine tax principles, “primarily” is interpreted as more than 50% of the time.12

This distinction allows biotechnology companies to utilize dual-use equipment—such as high-powered computing clusters or specialized storage—for both experimental research and secondary activities, provided the research use remains the predominant function of the asset. Furthermore, the biotechnology provision is broader in its definition of qualifying property. While the general R&D exemption focuses on “machinery and equipment,” the biotech exemption explicitly includes “supplies,” such as microscopes, glassware, chemical reagents, diagnostic testing materials, computer software, and technical manuals.2 This recognition of supplies as exempt property significantly expands the tax-saving potential for firms engaged in recombinant DNA techniques, biochemistry, and biological cell fusion.2

Comparing Exemption Standards across Industry Segments

The following table illustrates the variance in legal standards applied to different industrial and scientific sectors in Maine, highlighting the heightened scrutiny applied to general R&D versus the more permissive standards for biotech and manufacturing.

The “direct” usage requirement remains a constant across these categories, defined by Maine Revenue Services as activities that constitute an integral and essential part of the production or research process, as contrasted with activities that are simply incidental, convenient, or remote.12

Administrative Guidance and Local Revenue Office Interpretations

The Maine Revenue Services (MRS) provides detailed guidance on the application of the R&D sales tax exemption through Instructional Bulletins and formal Rules. Instructional Bulletin No. 22, specifically designed for manufacturers and industrial users, integrates the R&D exemption into the broader context of industrial tax policy.2 This guidance is vital for taxpayers to ensure that their internal asset classification survives an audit by the State Tax Assessor.

Definitions of Machinery, Equipment, and Direct Use

Under MRS guidance, “machinery and equipment” includes not only the primary apparatus used in research but also repair and replacement parts.7 However, it specifically excludes “foundations” for machinery that are permanent supports, such as those composed of concrete.7 If a support structure can be dismantled and moved, it may be considered part of the machinery and therefore exempt; otherwise, the materials used for the foundation are subject to tax.7

The concept of “direct” use excludes support operations. For instance, equipment used in a machine shop to maintain R&D machinery is considered to be used in a support capacity and is not “directly” used in research.12 Similarly, testing for quality control is only considered “directly” in the production or research flow if the testing devices are physically incorporated into machinery that is otherwise exempt.14 This nuance requires companies to meticulously map the physical and functional role of every piece of equipment in their laboratory or pilot plant.

Consumed or Destroyed Items and Rule 303

Rule 303, “Sales to Industrial Users,” further clarifies the treatment of items that are consumed or destroyed in the research process.14 While § 1760(32) focuses on capital equipment, the broader sales tax code provides exemptions for items that lose their identity or are destroyed within one year of use, provided they are integrated with and essential to the operation of exempt machinery.12

However, Rule 303 contains a critical exclusion: chemicals or supplies used in quality control and research laboratories are generally taxable unless they fall under the specific biotechnology exemption.14 This creates a bifurcated system where a general tech firm must pay sales tax on its lab chemicals, while a biotech firm may purchase the same chemicals tax-free. This discrepancy underscores the state’s intent to provide a competitive advantage to the biotechnology industry as a core economic pillar.2

The Industrial Users Blanket Certificate of Exemption

The mechanism for exercising the sales tax exemption at the point of purchase is the “Industrial Users Blanket Certificate of Exemption” (Form ST-A-117).15 This form serves as the primary evidence for a retailer that a transaction is non-taxable under the law.

The purchaser must certify that they hold a valid Seller’s Registration Certificate and are engaged in a qualifying form of production or research.15 By signing the certificate, the purchaser assumes full liability for the payment of any use taxes, penalties, and interest if the property is later used in a taxable manner.14 MRS guidance emphasizes that the certificate must be kept on file by the retailer and that each invoice must be appropriately marked “Maine Sales Tax Exempt”.15

The Research Expense Tax Credit: Operational Synergy

The Maine Research Expense Tax Credit (RETC), codified in 36 M.R.S. § 5219-K, provides the second half of the R&D incentive package.5 While the sales tax exemption reduces the cost of “buying” the research environment, the RETC reduces the cost of “doing” the research.3

Federal Conformity and Qualified Research Expenses (QREs)

The Maine RETC is fundamentally built upon the federal Credit for Increasing Research Activities under Internal Revenue Code (IRC) Section 41.3 Maine law explicitly adopts the federal definitions for “qualified research expenses,” “basic research,” and “qualified research”.5 This conformity is a critical efficiency for taxpayers, as it allows them to utilize the rigorous “Four-Part Test” established by the IRS to qualify their activities for the state credit.11

1. Technological in Nature: The research must fundamentally rely on the principles of physical or biological science, engineering, or computer science.11
2. Permitted Purpose: The activity must be intended to improve the functionality, performance, reliability, or quality of a business component.11
3. Elimination of Uncertainty: The research must discover information that addresses technical uncertainty regarding the capability, method, or design of a product or process.11
4. Process of Experimentation: The taxpayer must engage in a systematic evaluation of alternatives, such as through modeling, simulation, or trial-and-error testing.11

Crucially, the Maine credit is restricted only to those expenses incurred for research “conducted in Maine”.3 This requires companies with multi-state operations to apportion their federal QREs to reflect only the labor and supplies utilized within Maine’s borders.4

Calculation of the Credit Amount

The Maine RETC is an incremental credit, meaning it rewards businesses for increasing their research spending compared to a historical baseline.3 The credit is the sum of two distinct calculations:

1. 5% of the Excess QREs: The credit applies to the amount by which the current year’s Maine QREs exceed the “base amount”.4 The base amount is the average of the qualified research expenses spent in Maine over the previous three taxable years.5
2. 7.5% of Basic Research Payments: This component applies to payments made to qualified organizations (such as the University of Maine) for basic research, as determined under IRC § 41(e)(1)(A).1

The mathematical representation of the total Maine Research Expense Tax Credit ($C$) is:

$$C = +$$

If a taxpayer has no research history in the state for the prior three years, the base amount is zero, allowing for a substantial credit in the first year of innovation.4

Limitations on the Offset of Tax Liability

Unlike the sales tax exemption, which provides a 100% waiver of the specific tax on a purchase, the income tax credit is subject to statutory caps regarding how much total tax liability it can offset in a given year.5

The non-refundable nature of the credit means that if a company has no tax liability—a common scenario for early-stage tech startups—the credit cannot be converted to cash.4 However, the generous 15-year carryforward period allows these credits to remain “on the books” as a deferred tax asset, which can be used to offset future taxes once the R&D efforts translate into commercial revenue.3

Interplay: When Sales Tax and Income Tax Incentives Diverge

A critical insight for tax planning in Maine is the divergence in what constitutes an “eligible expense” between the sales tax exemption and the income tax credit. Under federal and state income tax law, depreciable property (such as machinery and equipment) is generally excluded from the definition of Qualified Research Expenses (QREs).5 Instead, capital assets are recovered through depreciation over their useful life.

Consequently, a machine used for R&D does not generate a 5% income tax credit on its purchase price. However, it does qualify for the 5.5% sales tax exemption at the time of purchase.1 The operational synergy occurs because:

• The Sales Tax Exemption handles the “Capital Investment” (the hardware).1
• The Research Expense Tax Credit handles the “Operational Investment” (the labor and non-capital supplies).3

By utilizing both, a Maine innovator can effectively subsidize every stage of the R&D lifecycle.

Comprehensive Case Study: BioVanguard Innovations LLC

BioVanguard Innovations LLC is a mid-sized biotechnology firm based in Bangor, Maine. In 2024, the company embarked on a project to develop a new synthetic protein for pharmaceutical use.

Capital Acquisition and Sales Tax Application

BioVanguard purchased a high-resolution mass spectrometer and several specialized refrigeration units for their lab, totaling $500,000. At the time of purchase, they provided their vendors with Form ST-A-117, claiming the biotechnology exemption under § 1760(32).15

• Standard Sales Tax (5.5%): $27,500.
• Tax Paid: $0 (Exemption applied).1
• Compliance: Because these are biotechnology applications, BioVanguard only needs to ensure the equipment is used “primarily” (more than 50%) for research, providing greater operational flexibility than a traditional engineering firm would have.2

Operational Expenditure and Income Tax Credit

During the 2024 tax year, BioVanguard incurred the following Maine-based expenses:

• Wages for researchers: $800,000.
• Lab supplies and reagents: $150,000.
• Contract research with the University of Maine: $50,000.

Total 2024 QREs: $950,000.

Historical Base Amount Calculation:

BioVanguard’s QREs for the three prior years were:

• 2021: $600,000.
• 2022: $700,000.
• 2023: $800,000.
• Average Base Amount: ($600k + $700k + $800k) / 3 = $700,000.4

RETC Calculation:

1. Incremental Credit: 5% of ($950,000 – $700,000) = $12,500.
2. Basic Research Credit: 7.5% of $50,000 = $3,750.
3. Total Credit Earned: $16,250.4

Tax Liability Offset:

Assuming BioVanguard’s 2024 Maine corporate income tax liability before credits is $40,000:

• First $25,000 offset: $16,250 is less than $25,000, so it is fully deductible.5
• Net Tax Due: $40,000 – $16,250 = $23,750.

Through the strategic use of both incentives, BioVanguard saved a total of $43,750 ($27,500 in sales tax and $16,250 in income tax) in a single year.

Fiscal Impact and Economic Statistics

The state’s commitment to these incentives is reflected in the annual “Tax Expenditure Report” and the evaluations performed by the Office of Program Evaluation and Government Accountability (OPEGA).3

Revenue Loss Trends

According to recent data, the Research Expense Tax Credit results in a general fund revenue loss of approximately $3.2 million annually.3 The NMER sales tax exemption, being more narrowly focused on 100% exclusive machinery, has a smaller but significant impact, with estimated revenue losses ranging between $50,000 and $249,000 annually.2

The growth in these figures suggests an increasing utilization of the credit by Maine’s technology and manufacturing sectors, even as OPEGA notes that lack of transparent data makes it difficult to judge the exact effectiveness of these incentives in attracting new companies to the state.23

OPEGA Recommendations and Future Outlook

In its 2022 evaluation, OPEGA recommended reclassifying the R&D sales tax exemption into the “Rationale category of Inputs to Tangible Products”.2 This recommendation is significant because it moves the exemption from being seen as a “Business Incentive” (a reward for behavior) to a structural component of a fair tax system (avoiding the taxation of inputs to production).2 This suggests a long-term stability for the exemption, as it aligns with the core principles of avoiding multiple layers of sales tax on manufacturers.2

Reporting Requirements and Compliance Procedures

To successfully claim and maintain these R&D incentives, taxpayers must navigate a specific set of administrative hurdles. Failure to comply with these procedures can result in the recapture of tax benefits and the assessment of penalties.

Filing the Research Expense Tax Credit

The RETC is claimed as part of the taxpayer’s state income tax return—Form 1120ME for corporations or Form 1040ME for individuals.4 The taxpayer must complete the “Research Expense Tax Credit Worksheet” and attach a copy of their federal Form 6765.4

The worksheet requires detailed reporting of:

• Maine basic research payments.19
• Total Maine QREs for the current year.19
• The three-year average of Maine QREs (the base amount).19
• Any unused credit carryforwards from prior years.19

The Sales Tax Refund Path (Form APP-153)

If a taxpayer pays sales tax on qualifying R&D equipment at the time of purchase—perhaps because they did not have an exemption certificate ready—they may apply for a refund within three years of the purchase date.24

The “Application for Refund of Sales or Use Tax” (Form APP-153) requires:

• A cover letter detailing the specific research use of the equipment.24
• Proof that the tax was paid (invoices and payment evidence).24
• A description of the equipment and confirmation of its 100% depreciability for federal tax purposes.24

MRS routinely audits these refund requests, often requesting project logs or lab blueprints to verify the “direct and exclusive” use requirement.18

Conclusion: A Strategic Framework for Maine Innovation

The interplay between the R&D Sales Tax Exemption and the Research Expense Tax Credit creates a robust framework for technological investment in Maine. By addressing both the high upfront costs of laboratory machinery and the ongoing operational costs of scientific labor, the state provides a comprehensive support system for innovation-driven businesses.

While the “directly and exclusively” standard for general R&D equipment remains a high bar, the more permissive standards for the biotechnology sector highlight the state’s proactive approach to industry-specific growth. For the professional peer and the business strategist, the key to maximizing these benefits lies in meticulous contemporaneous record-keeping and a deep understanding of the statutory boundaries that separate routine business activities from the “experimental and laboratory sense” of true research. As Maine continues to evolve its tax code, these R&D incentives will remain a cornerstone of its efforts to cultivate a competitive, high-technology economy in Northern New England.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/